BACKGROUND: We present our initial single-centre experience with Senhance surgical robot-assisted colorectal surgery and examine its safety and feasibility. METHODS: From June 2019 to December 2019, patients who underwent Senhance surgical robot-assisted colorectal surgery in our hospital were retrospectively analysed. We focused on the short-term outcomes. RESULTS: In total, 46 patients were enrolled in the study. Colorectal cancer was the most common indication for surgery (39 patients). The median total operation time was 283 min, and the median blood loss was 50 cc. Meanwhile, the median number of harvested lymph nodes was 20. Elderly age, advanced American Society of Anaesthesiologists stage, and right-sided colon surgery were associated with the occurrence of complications greater than grade III. CONCLUSION: Our findings demonstrate the feasibility and safety of the Senhance surgical robotic system in colorectal surgery. Care should be taken regarding the indications and patient selection.
BACKGROUND: We present our initial single-centre experience with Senhance surgical robot-assisted colorectal surgery and examine its safety and feasibility. METHODS: From June 2019 to December 2019, patients who underwent Senhance surgical robot-assisted colorectal surgery in our hospital were retrospectively analysed. We focused on the short-term outcomes. RESULTS: In total, 46 patients were enrolled in the study. Colorectal cancer was the most common indication for surgery (39 patients). The median total operation time was 283 min, and the median blood loss was 50 cc. Meanwhile, the median number of harvested lymph nodes was 20. Elderly age, advanced American Society of Anaesthesiologists stage, and right-sided colon surgery were associated with the occurrence of complications greater than grade III. CONCLUSION: Our findings demonstrate the feasibility and safety of the Senhance surgical robotic system in colorectal surgery. Care should be taken regarding the indications and patient selection.
Authors: N E Samalavicius; A Dulskas; V Janusonis; V Klimasauskiene; V Eismontas; O Deduchovas; T Janusonis; R Markelis; E Smolskas Journal: Tech Coloproctol Date: 2022-03-19 Impact factor: 3.699